Alaunos Historical Income Statement
| TCRT Stock | USD 1.16 0.06 4.92% |
Historical analysis of Alaunos Therapeutics income statement accounts such as Research Development of 15.5 M, Selling General Administrative of 16.3 M, Interest Expense of 1.8 M or Reconciled Depreciation of 1.9 M can show how well Alaunos Therapeutics performed in making a profits. Evaluating Alaunos Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Alaunos Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Alaunos Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Alaunos Therapeutics is a good buy for the upcoming year.
Alaunos |
About Alaunos Income Statement Analysis
Alaunos Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Alaunos Therapeutics shareholders. The income statement also shows Alaunos investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Alaunos Therapeutics Income Statement Chart
Alaunos Therapeutics Income Statement is one of the three primary financial statements used for reporting Alaunos's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Alaunos Therapeutics revenue and expense. Alaunos Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Alaunos Therapeutics' Depreciation And Amortization is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 52.2 M in 2024, despite the fact that Gross Profit is likely to grow to (2.2 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Alaunos Therapeutics. It is also known as Alaunos Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Alaunos Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Alaunos Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Alaunos Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Alaunos Stock please use our How to Invest in Alaunos Therapeutics guide.At this time, Alaunos Therapeutics' Depreciation And Amortization is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 52.2 M in 2024, despite the fact that Gross Profit is likely to grow to (2.2 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 740K | 2.8M | 2.3M | 1.7M | Reconciled Depreciation | 2.6M | 2.8M | 2.8M | 1.9M |
Alaunos Therapeutics income statement Correlations
Click cells to compare fundamentals
Alaunos Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alaunos Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 629K | 1.1M | 1.5M | 396K | 2.3M | 2.4M | |
| Gross Profit | (629K) | (1.1M) | (342K) | 163K | (2.3M) | (2.2M) | |
| Other Operating Expenses | 57.9M | 80.4M | 77.2M | 38.2M | 28.5M | 52.2M | |
| Operating Income | 2.3M | (80.4M) | (77.5M) | (35.1M) | (28.5M) | (29.9M) | |
| Ebit | 2.3M | (80.4M) | (77.5M) | (35.1M) | (28.5M) | (29.9M) | |
| Ebitda | 2.9M | (79.2M) | (76.1M) | (34.7M) | (26.2M) | (27.5M) | |
| Total Operating Expenses | 57.9M | 80.4M | 77.2M | 38.2M | 26.2M | 52.1M | |
| Income Before Tax | (117.8M) | (80.0M) | (78.8M) | (37.7M) | (35.1M) | (36.9M) | |
| Net Income | (177.9M) | (78.8M) | (76.9M) | (37.6M) | (35.1M) | (36.9M) | |
| Research Development | 38.3M | 52.7M | 49.6M | 25.0M | 16.3M | 15.5M | |
| Income Tax Expense | 60.1M | (1.1M) | (1.9M) | (133K) | (153.0K) | (145.3K) | |
| Selling General Administrative | 19.5M | 27.7M | 27.6M | 13.1M | 12.2M | 16.3M | |
| Total Other Income Expense Net | (120.1M) | 385K | (1.2M) | (2.6M) | (6.6M) | (7.0M) | |
| Interest Expense | 120.7M | 385K | 1.2M | 3.2M | 1.9M | 1.8M | |
| Net Income Applicable To Common Shares | (117.8M) | (80.0M) | (78.8M) | (37.7M) | (34.0M) | (35.7M) | |
| Net Income From Continuing Ops | (117.8M) | (80.0M) | (78.8M) | (37.7M) | (36.5M) | (38.3M) | |
| Reconciled Depreciation | 629K | 1.1M | 2.6M | 2.8M | 2.8M | 1.9M |
Pair Trading with Alaunos Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alaunos Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alaunos Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Alaunos Stock
| 0.86 | VRDN | Viridian Therapeutics | PairCorr |
| 0.82 | EFTR | Effector Therapeutics | PairCorr |
Moving against Alaunos Stock
| 0.64 | ELYM | Eliem Therapeutics | PairCorr |
| 0.59 | DSGN | Design Therapeutics | PairCorr |
| 0.42 | ELVN | Enliven Therapeutics | PairCorr |
The ability to find closely correlated positions to Alaunos Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alaunos Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alaunos Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alaunos Therapeutics to buy it.
The correlation of Alaunos Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alaunos Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alaunos Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alaunos Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Alaunos Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Alaunos Stock please use our How to Invest in Alaunos Therapeutics guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Alaunos Stock analysis
When running Alaunos Therapeutics' price analysis, check to measure Alaunos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alaunos Therapeutics is operating at the current time. Most of Alaunos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alaunos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alaunos Therapeutics' price. Additionally, you may evaluate how the addition of Alaunos Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Alaunos Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alaunos Therapeutics. If investors know Alaunos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alaunos Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (33.00) | Quarterly Revenue Growth (0.91) | Return On Assets (0.49) | Return On Equity (1.57) |
The market value of Alaunos Therapeutics is measured differently than its book value, which is the value of Alaunos that is recorded on the company's balance sheet. Investors also form their own opinion of Alaunos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alaunos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alaunos Therapeutics' market value can be influenced by many factors that don't directly affect Alaunos Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alaunos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alaunos Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alaunos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.